BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27353138)

  • 1. [Detection of alpha-1 antitrypsin deficiency: A study on patients diagnosed with chronic obstructive pulmonary disease in primary health care].
    García-Palenzuela R; Timiraos Carrasco R; Gómez-Besteiro MI; Lavia G; Lago Pose M; Lara B
    Semergen; 2017; 43(4):289-294. PubMed ID: 27353138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
    Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
    Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
    Lara B; Miravitlles M
    COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Alpha-1 Antitrypsin Deficiency in COPD Patients in Argentina. The DAAT.AR Study.
    Menga G; Fernandez Acquier M; Echazarreta AL; Sorroche PB; Lorenzon MV; Fernández ME; Saez MS;
    Arch Bronconeumol (Engl Ed); 2020 Sep; 56(9):571-577. PubMed ID: 31889566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European screening for alpha
    Greulich T; Averyanov A; Borsa L; Rozborilová E; Vaicius D; Major T; Chopyak V; Tudorache V; Konstantinova T; Camprubí S
    Clin Respir J; 2017 Jan; 11(1):90-97. PubMed ID: 25919395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.
    Tural Onur S; Natoli A; Dreger B; Arınç S; Sarıoğlu N; Çörtük M; Karadoğan D; Şenyiğit A; Yıldız BP; Köktürk N; Argun Barıs S; Kodalak Cengiz S; Polatli M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2785-2794. PubMed ID: 38046982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain].
    Blanco I; Fernández-Bustillo E; de Serres FJ; Alkassam D; Rodríguez Menéndez C
    Med Clin (Barc); 2004 Dec; 123(20):761-5. PubMed ID: 15607066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
    Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
    Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
    Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
    Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.
    Hernández-Pérez JM; Ramos-Díaz R; Vaquerizo-Pollino C; Pérez JA
    Pulmonology; 2023; 29(3):214-220. PubMed ID: 35346640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of PI*S and PI*Z SERPINA1 alleles in healthy individuals and COPD patients in Saudi Arabia: A case-control study.
    Al-Jameil N; Hassan AA; Hassanato R; Isac SR; Otaiby MA; Al-Shareef F; Al-Maarik B; Ajeyan IA; Al-Bahloul K; Ghani S; Al-Torbak D
    Medicine (Baltimore); 2017 Oct; 96(42):e8320. PubMed ID: 29049242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia.
    Alí-Munive A; Leidy P; Proaños NJ; Pedrozo-Pupo J; Giraldo A; Cano D; Diaz-Bossa C; Mosquera R; Paul H; Gonzalez-García M; Aguirre-Franco C; López-Campos JL; Casas-Herrera A
    BMC Pulm Med; 2023 May; 23(1):156. PubMed ID: 37143026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency.
    Greulich T; Rodríguez-Frias F; Belmonte I; Klemmer A; Vogelmeier CF; Miravitlles M
    Respir Res; 2018 Aug; 19(1):151. PubMed ID: 30103740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
    O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
    COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
    Calle Rubio M; Soriano JB; López-Campos JL; Soler-Cataluña JJ; Alcázar Navarrete B; Rodríguez González-Moro JM; Miravitlles M; Barrecheguren M; Fuentes Ferrer ME; Rodriguez Hermosa JL;
    PLoS One; 2018; 13(6):e0198777. PubMed ID: 29953442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of candidates for lung transplantation due to chronic obstructive pulmonary disease and alpha-1 antitrypsin deficiency emphysema.
    Giacoboni D; Barrecheguren M; Esquinas C; Rodríguez E; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Pirina P; Miravitlles M; Román A
    Arch Bronconeumol; 2015 Aug; 51(8):379-83. PubMed ID: 25301410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IDDEA project: a strategy for the detection of alpha-1 antitrypsin deficiency in COPD patients in the primary care setting.
    Molina J; Flor X; García R; Timiraos R; Tirado-Conde G; Miravitlles M
    Ther Adv Respir Dis; 2011 Aug; 5(4):237-43. PubMed ID: 21652608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.